The strategic alliance enables Vivli and TrialScope to promote transparency and data sharing to advance scientific discoveries, reduce redundancies and improve patient care.
JERSEY CITY, N.J. /PRNewswire/ -- TrialScope, the global leader in clinical trial transparency, compliance and patient engagement solutions, today announced a strategic partnership with Vivli, a nonprofit organization focused on sharing of clinical trial data through its innovative platform. The collaboration will offer sponsors and researchers access to the most complete solution for disclosure and data sharing.
TrialScope's SaaS-based, centralized approach has met the disclosure and transparency needs of the trial industry from large pharmaceutical companies (13 of the top 15) to smaller biotech firms for more than five years. By working with Vivli, the company can offer its customers the most comprehensive approach to disclosure and data sharing in the market.
The alliance draws on complementary strengths of each partner and will deliver an opportunity for industry and academic sponsors to address all their disclosure and transparency needs, such as:
- Disclosure and data-sharing software and advisory services
- Technology to help people find help people find relevant, authoritative clinical trial information online
- Plain-Language Summary authoring and hosting
- End-to-end workflow support to manage data-sharing requests, including full data process preparation (collate, redact, anonymize, review, approve)
- Access to an independent data-sharing review panel
- The ability to host anonymized Individual Participant Data (IPD)
- The ability for sponsors to share their data in a secure research environment.
"There is a growing trend towards increased transparency within the clinical trial industry, not just to meet regulatory requirements, but as an ethical obligation to advance science and promote patient safety," said TrialScope CEO Jeff Kozloff. "We are honored to work with Vivli as a partner to provide our customers with a seamless and efficient platform for all of their data-sharing needs. We appreciate the fact that Vivli is disease agnostic and can synthesize data from multiple repositories, which will greatly reduce duplication of clinical trials, putting fewer patients through studies unnecessarily."
Vivli, which launched in July 2018, is already receiving enthusiastic industry support and demand for its platform, which now hosts more than 3,200 trials conducted in 100 different countries from 16 members.
"We are delighted to partner with TrialScope, which is recognized as the leader in clinical trial disclosure," said Rebecca Li, Ph.D., Executive Director of Vivli. "Together, we offer an end-to-end solution. There is simply no complete solution for researchers and sponsors alike, who want to spend less time searching for previous data, and more time on advancing science."
Julie Wood, Vivli's Director of Strategy and Operations, and Thomas Wicks, TrialScope's Chief Strategy Officer, will be co-presenting at CBI's 6th annual Clinical Data Disclosure and Transparency conference. They will explore the "Disclosure and Data Sharing Lifecycle" for attendees Jan. 30 at 9:30am ET in Philadelphia.
TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 13 of the top 15 industry clinical trial sponsors worldwide. TrialScope provides proven solutions that optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing. To learn more about TrialScope, visit TrialScope.com.
Alyson Kuritz for TrialScope
Julie Wood for Vivli